董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Julian Aleksov | 男 | Executive Chairman of the Board | 52 | 281.40万瑞典克朗 | 未持股 | 2017-08-24 |
| Bo Cederstrand | 男 | Director | 78 | 17.50万瑞典克朗 | 未持股 | 2017-08-24 |
| Alexander Kotsinas | 男 | Director | 49 | 11.70万瑞典克朗 | 未持股 | 2017-08-24 |
| Lars Bergkvist | 男 | Director | 53 | 8.20万瑞典克朗 | 未持股 | 2017-08-24 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Julian Aleksov | 男 | Executive Chairman of the Board | 52 | 281.40万瑞典克朗 | 未持股 | 2017-08-24 |
| Mikael Asp | 男 | Chief Executive Officer and Head of Quality Assurance | 54 | 19.70万瑞典克朗 | 未持股 | 2017-08-24 |
| Anders Blom | 男 | Executive Vice President | 48 | 未披露 | 未持股 | 2017-08-24 |
| Fredrik Gynnerstedt | 男 | Chief Financial Officer | 41 | 未披露 | 未持股 | 2017-08-24 |
董事简历
中英对照 | 中文 | 英文- Julian Aleksov
-
Julian Aleksov，他是Oasmia公司的联席创始人，也曾担任首席执行官兼董事（1999年以来），也曾担任Oasmia公司的前身公司的董事（从1998年到1999年）。他于2015年5月28日辞去了首席执行官，并被任命为我们的董事会执行主席。他是一个经验丰富的经济学家，涉及协调全球知识产权资产的研究项目和战略发展。成为首席执行官之前，他曾负责监管我们的生物有机化学研究和战略发展，专注于类维生素a和α蛋白粘合剂，也曾管理我们的全球无形资产登记和融资。他一直担任Alceco公司（我们的主要股东之一）的合伙人兼董事会成员（2000年以来）。他也曾就读于斯德哥尔摩德国学校（Deutsche Schule）的基础教育，随后在几个层面上研究经济学。
Julian Aleksov is a co-founder of Oasmia, and has served as Chief Executive Officer and a director since 1999 though he was a director of Oasmia’s predecessor from 1998 to 1999. On May 28 2015 he resigned as our Chief Executive Officer and was appointed as our Executive Chairman of the Board. During the Extraordinary General Meeting held in November 2016 he was appointed Vice Executive Chairman, however in February 2017 he was re-appointed as Executive Chairman of the Board.Prior to becoming the CEO, he oversaw our research and strategic development within bio-organic chemistry, with a focus on retinoids and alpha-protein bindings, while also managing our global intangible assets registrations and financing. He has been a partner and member of the board of Alceco, one of our principal stockholders, since 2000. He attended the Deutsche Schule in Stockholm for his basic education, and thereafter studied economics on several levels. - Julian Aleksov，他是Oasmia公司的联席创始人，也曾担任首席执行官兼董事（1999年以来），也曾担任Oasmia公司的前身公司的董事（从1998年到1999年）。他于2015年5月28日辞去了首席执行官，并被任命为我们的董事会执行主席。他是一个经验丰富的经济学家，涉及协调全球知识产权资产的研究项目和战略发展。成为首席执行官之前，他曾负责监管我们的生物有机化学研究和战略发展，专注于类维生素a和α蛋白粘合剂，也曾管理我们的全球无形资产登记和融资。他一直担任Alceco公司（我们的主要股东之一）的合伙人兼董事会成员（2000年以来）。他也曾就读于斯德哥尔摩德国学校（Deutsche Schule）的基础教育，随后在几个层面上研究经济学。
- Julian Aleksov is a co-founder of Oasmia, and has served as Chief Executive Officer and a director since 1999 though he was a director of Oasmia’s predecessor from 1998 to 1999. On May 28 2015 he resigned as our Chief Executive Officer and was appointed as our Executive Chairman of the Board. During the Extraordinary General Meeting held in November 2016 he was appointed Vice Executive Chairman, however in February 2017 he was re-appointed as Executive Chairman of the Board.Prior to becoming the CEO, he oversaw our research and strategic development within bio-organic chemistry, with a focus on retinoids and alpha-protein bindings, while also managing our global intangible assets registrations and financing. He has been a partner and member of the board of Alceco, one of our principal stockholders, since 2000. He attended the Deutsche Schule in Stockholm for his basic education, and thereafter studied economics on several levels.
- Bo Cederstrand
-
Bo Cederstrand，他一直担任公司的董事（2000年以来），以及董事会主席（从2000年到2011年）。他拥有近40年经验，作为多家中小企业（专门从事宠物或者宠物用品，其中大部分公司是他创立的）的首席执行官兼合伙人。他拥有国际贸易和生产的丰富经验，并一直积极参与贸易分支协会。他一直担任Alceco公司（我们的主要股东之一）的合伙人兼董事会成员（2000年以来）。他是Fruges Aktiebolag公司的副董事会成员，也曾担任Arkenbutikerna公司的前董事会成员。他也曾就读于the Stockholm School of Economics。
Bo Cederstrand has been a director since 2000 and was Chairman of the Board from 2000 to 2011. He has approximately 40 years of experience as CEO and partner in a number of small and medium-sized companies specializing in pets or pet products, most of which he founded.He has been a partner and member of the board of Alceco, one of our principal stockholders, since 2000. He is a deputy board member at Fruges Aktiebolag AB and was a previous board member of Arkenbutikerna. He studied at the Stockholm School of Economics. - Bo Cederstrand，他一直担任公司的董事（2000年以来），以及董事会主席（从2000年到2011年）。他拥有近40年经验，作为多家中小企业（专门从事宠物或者宠物用品，其中大部分公司是他创立的）的首席执行官兼合伙人。他拥有国际贸易和生产的丰富经验，并一直积极参与贸易分支协会。他一直担任Alceco公司（我们的主要股东之一）的合伙人兼董事会成员（2000年以来）。他是Fruges Aktiebolag公司的副董事会成员，也曾担任Arkenbutikerna公司的前董事会成员。他也曾就读于the Stockholm School of Economics。
- Bo Cederstrand has been a director since 2000 and was Chairman of the Board from 2000 to 2011. He has approximately 40 years of experience as CEO and partner in a number of small and medium-sized companies specializing in pets or pet products, most of which he founded.He has been a partner and member of the board of Alceco, one of our principal stockholders, since 2000. He is a deputy board member at Fruges Aktiebolag AB and was a previous board member of Arkenbutikerna. He studied at the Stockholm School of Economics.
- Alexander Kotsinas
-
Alexander Kotsinas ， 他任职于我们的董事会（2013年9月以来）。他一直担任Nexttobe公司的合伙人（2011年以来），此前曾担任Ericsson Softlab公司的董事会成员。他曾担任Q-Med公司的副总裁兼首席财务官（从2008年到2011年），也曾于2007年担任Life Europe公司的首席财务官，还曾担任Tre-Hi3G Access公司的首席财务官（从2003年到2006年）。他持有斯德哥尔摩皇家理工学院（the Royal Institute of Technology, Stockholm）的应用物理科学硕士学位，以及the Stockholm School of Economics的经济学学士学位。
Alexander Kotsinas has served on our board of directors since September 2013. He is currently working as an independent consultant for Nexttobe AB since 2016 and has worked as a Partner at Nexttobe AB from 2011 to 2016. He has been Vice President at Investor AB and has worked at Ericsson. He was the Vice President and CFO at Q-Med AB from 2008 to 2011 and was the CFO at Life Europe AB in 2007 and at Tre-Hi3G Access AB from 2003 to 2006. He has a Master of Science degree in Applied Physics from the Royal Institute of Technology, Stockholm and a Bachelor of Science Economics from the Stockholm School of Economics. - Alexander Kotsinas ， 他任职于我们的董事会（2013年9月以来）。他一直担任Nexttobe公司的合伙人（2011年以来），此前曾担任Ericsson Softlab公司的董事会成员。他曾担任Q-Med公司的副总裁兼首席财务官（从2008年到2011年），也曾于2007年担任Life Europe公司的首席财务官，还曾担任Tre-Hi3G Access公司的首席财务官（从2003年到2006年）。他持有斯德哥尔摩皇家理工学院（the Royal Institute of Technology, Stockholm）的应用物理科学硕士学位，以及the Stockholm School of Economics的经济学学士学位。
- Alexander Kotsinas has served on our board of directors since September 2013. He is currently working as an independent consultant for Nexttobe AB since 2016 and has worked as a Partner at Nexttobe AB from 2011 to 2016. He has been Vice President at Investor AB and has worked at Ericsson. He was the Vice President and CFO at Q-Med AB from 2008 to 2011 and was the CFO at Life Europe AB in 2007 and at Tre-Hi3G Access AB from 2003 to 2006. He has a Master of Science degree in Applied Physics from the Royal Institute of Technology, Stockholm and a Bachelor of Science Economics from the Stockholm School of Economics.
- Lars Bergkvist
-
Lars Bergkvist，他担任我们的董事（2015年5月以来）。从2001年到2011年，他是Arken Zoo公司的首席执行官。2012年以来，他也曾担任Jaktia AB、Master Design AB、Chainformation AB的董事会主席，以及FDT AB（上市公司）董事会成员、Skyltspektrum AB的顾问委员会的成员。他于1986年获得Stockholm’s School of Economics的会计和财务学位。
Lars Bergkvist has served on our board of directors since May 2015. From 2001 through 2011 he was the chief executive officer at Arken Zoo. Since 2012 he has acted as the chairman of the board of Jaktia AB, Master Design AB and Chainformation AB, as a member of the board of directors of FDT AB, a public company, and as a member of the advisory board of Skyltspektrum AB. He received a degree in Accounting and Finance from Stockholm’s School of Economics in 1986. - Lars Bergkvist，他担任我们的董事（2015年5月以来）。从2001年到2011年，他是Arken Zoo公司的首席执行官。2012年以来，他也曾担任Jaktia AB、Master Design AB、Chainformation AB的董事会主席，以及FDT AB（上市公司）董事会成员、Skyltspektrum AB的顾问委员会的成员。他于1986年获得Stockholm’s School of Economics的会计和财务学位。
- Lars Bergkvist has served on our board of directors since May 2015. From 2001 through 2011 he was the chief executive officer at Arken Zoo. Since 2012 he has acted as the chairman of the board of Jaktia AB, Master Design AB and Chainformation AB, as a member of the board of directors of FDT AB, a public company, and as a member of the advisory board of Skyltspektrum AB. He received a degree in Accounting and Finance from Stockholm’s School of Economics in 1986.
高管简历
中英对照 | 中文 | 英文- Julian Aleksov
Julian Aleksov，他是Oasmia公司的联席创始人，也曾担任首席执行官兼董事（1999年以来），也曾担任Oasmia公司的前身公司的董事（从1998年到1999年）。他于2015年5月28日辞去了首席执行官，并被任命为我们的董事会执行主席。他是一个经验丰富的经济学家，涉及协调全球知识产权资产的研究项目和战略发展。成为首席执行官之前，他曾负责监管我们的生物有机化学研究和战略发展，专注于类维生素a和α蛋白粘合剂，也曾管理我们的全球无形资产登记和融资。他一直担任Alceco公司（我们的主要股东之一）的合伙人兼董事会成员（2000年以来）。他也曾就读于斯德哥尔摩德国学校（Deutsche Schule）的基础教育，随后在几个层面上研究经济学。
Julian Aleksov is a co-founder of Oasmia, and has served as Chief Executive Officer and a director since 1999 though he was a director of Oasmia’s predecessor from 1998 to 1999. On May 28 2015 he resigned as our Chief Executive Officer and was appointed as our Executive Chairman of the Board. During the Extraordinary General Meeting held in November 2016 he was appointed Vice Executive Chairman, however in February 2017 he was re-appointed as Executive Chairman of the Board.Prior to becoming the CEO, he oversaw our research and strategic development within bio-organic chemistry, with a focus on retinoids and alpha-protein bindings, while also managing our global intangible assets registrations and financing. He has been a partner and member of the board of Alceco, one of our principal stockholders, since 2000. He attended the Deutsche Schule in Stockholm for his basic education, and thereafter studied economics on several levels.- Julian Aleksov，他是Oasmia公司的联席创始人，也曾担任首席执行官兼董事（1999年以来），也曾担任Oasmia公司的前身公司的董事（从1998年到1999年）。他于2015年5月28日辞去了首席执行官，并被任命为我们的董事会执行主席。他是一个经验丰富的经济学家，涉及协调全球知识产权资产的研究项目和战略发展。成为首席执行官之前，他曾负责监管我们的生物有机化学研究和战略发展，专注于类维生素a和α蛋白粘合剂，也曾管理我们的全球无形资产登记和融资。他一直担任Alceco公司（我们的主要股东之一）的合伙人兼董事会成员（2000年以来）。他也曾就读于斯德哥尔摩德国学校（Deutsche Schule）的基础教育，随后在几个层面上研究经济学。
- Julian Aleksov is a co-founder of Oasmia, and has served as Chief Executive Officer and a director since 1999 though he was a director of Oasmia’s predecessor from 1998 to 1999. On May 28 2015 he resigned as our Chief Executive Officer and was appointed as our Executive Chairman of the Board. During the Extraordinary General Meeting held in November 2016 he was appointed Vice Executive Chairman, however in February 2017 he was re-appointed as Executive Chairman of the Board.Prior to becoming the CEO, he oversaw our research and strategic development within bio-organic chemistry, with a focus on retinoids and alpha-protein bindings, while also managing our global intangible assets registrations and financing. He has been a partner and member of the board of Alceco, one of our principal stockholders, since 2000. He attended the Deutsche Schule in Stockholm for his basic education, and thereafter studied economics on several levels.
- Mikael Asp
Mikael Asp，他也曾担任质量保证主管（2013年以来）。他于2015年5月28日被任命为我们的首席执行官。他也曾任职国际制药行业的多家公司（包括Xellia公司、Pfizer公司、Wyeth公司、Pharmacia公司）25年，从事研究和开发、生产和质量保证。2013年以来，他一直是合规的人力资源官。他持有斯德哥尔摩皇家理工学院（Royal Institute of Technology, Stockholm）的化学工程硕士学位。
Mikael Asp has served as Head of Quality Assurance since 2013. On May 28, 2015, he was appointed as our Chief Executive Officer. He has 25 years of experience with a variety of companies in the international pharmaceutical sector including Xellia, Pfizer, Wyeth and Pharmacia in research and development, production and quality assurance. He has been a Qualified Person since 2013. He has a Master's degree in chemical engineering from Royal Institute of Technology, Stockholm.- Mikael Asp，他也曾担任质量保证主管（2013年以来）。他于2015年5月28日被任命为我们的首席执行官。他也曾任职国际制药行业的多家公司（包括Xellia公司、Pfizer公司、Wyeth公司、Pharmacia公司）25年，从事研究和开发、生产和质量保证。2013年以来，他一直是合规的人力资源官。他持有斯德哥尔摩皇家理工学院（Royal Institute of Technology, Stockholm）的化学工程硕士学位。
- Mikael Asp has served as Head of Quality Assurance since 2013. On May 28, 2015, he was appointed as our Chief Executive Officer. He has 25 years of experience with a variety of companies in the international pharmaceutical sector including Xellia, Pfizer, Wyeth and Pharmacia in research and development, production and quality assurance. He has been a Qualified Person since 2013. He has a Master's degree in chemical engineering from Royal Institute of Technology, Stockholm.
- Anders Blom
Anders Blom，他一直担任我们的执行副总裁（2014年9月1日以来）。他拥有15年的国际战略业务发展和金融业经验，任职于Galderma公司（原为Q-Med公司）和Pharmacia公司。他也是Nexttobe公司（Oasmia公司的第二大股东）的首席执行官。Nexttobe公司是生命科学公司（位于乌普萨拉），专注于风险资本。他持有Uppsala University的工商管理硕士学位。
Anders Blom has served as Executive Vice President since September 1, 2014. He has 15 years of experience from international strategic business development and finance at Galderma (former Q-Med AB) and Pharmacia. Anders was previously CEO of Nexttobe which is also the largest creditor in Oasmia. Nexttobe is a life science focused venture capital firm based in Uppsala. He has a Master of Business Administration degree from Uppsala University.- Anders Blom，他一直担任我们的执行副总裁（2014年9月1日以来）。他拥有15年的国际战略业务发展和金融业经验，任职于Galderma公司（原为Q-Med公司）和Pharmacia公司。他也是Nexttobe公司（Oasmia公司的第二大股东）的首席执行官。Nexttobe公司是生命科学公司（位于乌普萨拉），专注于风险资本。他持有Uppsala University的工商管理硕士学位。
- Anders Blom has served as Executive Vice President since September 1, 2014. He has 15 years of experience from international strategic business development and finance at Galderma (former Q-Med AB) and Pharmacia. Anders was previously CEO of Nexttobe which is also the largest creditor in Oasmia. Nexttobe is a life science focused venture capital firm based in Uppsala. He has a Master of Business Administration degree from Uppsala University.
- Fredrik Gynnerstedt
Fredrik Gynnerstedt自2016年11月21日起担任首席财务官，在国际工商管理和活动方面拥有15年的经验。此前，Fredrik曾被聘为Karnov Group协作总监。此前，他曾担任上市公司Bringwell AB的首席财务官，以及Ernst&Young的审计师和顾问。Fredrik持有Stockholm University工商管理硕士学位。
Fredrik Gynnerstedt has served as Chief Financial Officer since November 21 2016 and possesses 15 years' experience in international business administration and activities. Previously, Fredrik was employed as the Director of Collaboration at Karnov Group. Prior to that role, he served as Chief Financial Officer for publicly held Bringwell AB, and as auditor and consultant at Ernst & Young. Fredrik has a Master's degree in Business Administration from Stockholm University.- Fredrik Gynnerstedt自2016年11月21日起担任首席财务官，在国际工商管理和活动方面拥有15年的经验。此前，Fredrik曾被聘为Karnov Group协作总监。此前，他曾担任上市公司Bringwell AB的首席财务官，以及Ernst&Young的审计师和顾问。Fredrik持有Stockholm University工商管理硕士学位。
- Fredrik Gynnerstedt has served as Chief Financial Officer since November 21 2016 and possesses 15 years' experience in international business administration and activities. Previously, Fredrik was employed as the Director of Collaboration at Karnov Group. Prior to that role, he served as Chief Financial Officer for publicly held Bringwell AB, and as auditor and consultant at Ernst & Young. Fredrik has a Master's degree in Business Administration from Stockholm University.